2024-16391. Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I  

  • *         *         *         *         *         *         *
    (68) N- ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1 H -benzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N -desethyl isotonitazene) 9760
    (69) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1 H -benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: N -piperidinyl etonitazene; etonitazepipne) 9761
    *         *         *         *         *         *         *

Document Information

Effective Date:
7/29/2024
Published:
07/29/2024
Department:
Drug Enforcement Administration
Entry Type:
Rule
Action:
Temporary amendment; temporary scheduling order.
Document Number:
2024-16391
Dates:
This temporary scheduling order is effective July 29, 2024, until July 29, 2026. If this order is extended or made permanent, DEA will publish a document in the Federal Register.
Pages:
60817-60823 (7 pages)
Docket Numbers:
Docket No. DEA-1143
Topics:
Administrative practice and procedure, Drug traffic control, Reporting and recordkeeping requirements
PDF File:
2024-16391.pdf
Supporting Documents:
» Controlled Substances Ordering System Modernization
» Samidorphan_DEA_8F analysis_10-15-2020
» HHS Samidorphan 2020 01-09
CFR: (1)
21 CFR 1308